Nausea & Vomiting of Pregnancy: Prevention, Management, and Something Called Neiguan's Point?

Mar 15

Written By The OB/GYN Resident Survival Guide

Nausea and/or vomiting of pregnancy affects about 50–80% of pregnant patients, which means you will almost certainly be managing these patients in the ambulatory setting, in OB triage, and on the antepartum service. In this episode, we’re breaking down the full spectrum of the condition—from mild nausea to hyperemesis gravidarum—and walking through prevention strategies, non-pharmacologic options, and the full pharmacologic toolkit.

📌 If you’re a fourth-year medical student waiting on the match and planning to start OB/GYN residency this July, I put together a free resource to help you prepare for July 1st. Click here to get your copy—it’s free and doesn’t take long to go through.

The Spectrum: From Nausea to Hyperemesis Gravidarum

This condition exists on a spectrum:

Nausea alone
Nausea and retching
Nausea and vomiting
Hyperemesis gravidarum (the most severe end)

There is no universally accepted definition of hyperemesis gravidarum, but the commonly used diagnostic criteria are:

Persistent vomiting not related to any other cause (always rule out other underlying etiologies such as gastroparesis, gastric ulcer, pyelonephritis, DKA, etc.)
Evidence of starvation — typically ketonuria on urine dipstick
Weight loss of ≥5% of pre-pregnancy weight

You may also see electrolyte and endocrinologic abnormalities, though these aren’t required to meet criteria.

Why Does This Happen?

We don’t have a complete understanding of the etiology, but the leading theory is that symptoms are driven by the natural rise in hCG and estradiol that occurs in pregnancy. A few things support this:

Patients with placental conditions that cause elevated hCG (molar pregnancies, multiple gestations) have higher rates of nausea, vomiting, and hyperemesis gravidarum
Elevated estrogen is known to cause nausea even outside of pregnancy—think IV estrogen for acute AUB or combined oral contraceptives
Conditions associated with lower hCG and estradiol (like cigarette smoking) have been associated with lower rates of hyperemesis in multiple studies
There’s also an evolutionary adaptation theory—food aversions and sensory sensitivity may reduce exposure to substances that could harm the fetus, making this a survival mechanism of sorts

Management: Prevention, Non-Pharmacologic, and Pharmacologic

Prevention

Start a prenatal vitamin at least one month before conception. Evidence suggests this can reduce the severity and incidence of nausea and vomiting—get your patients started at the preconception counseling visit
Replace large meals with multiple small meals every 1–2 hours throughout the day to avoid having a full stomach
Swap fatty and spicy foods for bland, high-protein options
Avoid sensory triggers: extreme temperatures, strong fragrances, bright or flickering lights, and overexertion

Non-Pharmacologic Interventions

Replace iron-containing prenatal vitamins with folate-only supplements. Oral iron is a known GI irritant—remove it from the picture right away
Ginger supplements. Data is mixed, but some studies show benefit for nausea (less so for vomiting)
Acupressure at the Neiguan (P6) point (just below the wrist)—available via commercial wristbands. Data is mixed here too, but these bands have also been studied for chemotherapy-induced nausea with some promising results

Pharmacologic Interventions

First-line: Vitamin B6 (pyridoxine) + Doxylamine

These can be prescribed as separate tablets or as a combination product. Dosing ranges from one tablet at bedtime up to four tablets per day depending on the formulation. There’s also evidence that starting B6 + doxylamine before symptom onset in subsequent pregnancies (in patients with a history of nausea and vomiting) can reduce symptom severity when symptoms do develop.

Second-line: Dopamine Antagonists and Antihistamines

Dopamine antagonists:

Promethazine (Phenergan) — also available as a rectal suppository, which is great for patients who can’t tolerate pills but don’t need IV access
Metoclopramide (Reglan)
Prochlorperazine (Compazine)

Antihistamines:

Dimenhydrinate (Dramamine)
Diphenhydramine (Benadryl) — note the drowsiness side effect

⚠️ Important: Combining multiple dopamine antagonists—especially long-term—increases the risk of extrapyramidal symptoms like tardive dyskinesia and dystonia. Avoid those combinations when possible (though, in severe cases, combining these medications may be the only efficacious option).

Third-line: Ondansetron (Zofran)

Available in an orally dissolving tablet (ODT)—a huge win for patients who can’t swallow pills and don’t want a suppository.

A few important safety points:

Zofran is used increasingly in pregnancy, but safety data is still limited compared to first- and second-line options—particularly for use during early first trimester/organogenesis
Some evidence associates first trimester use with congenital anomalies (though most studies do not show this); ACOG recommends discussing this with patients before prescribing if they are under 10 weeks
Can prolong the QT interval—try to avoid in patients with underlying cardiac conditions or electrolyte abnormalities, and don’t combine with other QT-prolonging medications unless routinely obtaining EKGs

Fourth-line: Steroids (Methylprednisolone / Prednisone taper)

Reserved for refractory cases. There is a weak association between methylprednisolone use in the first trimester and fetal oral clefts—so until we have more data, avoid using this before 10 weeks if possible and coordinate with MFM.

A Note on Enteral and Parenteral Nutrition

For patients with hyperemesis refractory to the interventions above—those requiring multiple hospitalizations for hydration, antiemetics, and electrolyte replacement and who can’t maintain their weight—we sometimes need to bypass the mouth entirely to deliver nutrition.

Enteral feeds via NG tube are strongly preferred over TPN via PICC line. Here’s why:

PICC insertion and TPN use in pregnancy carry a significantly higher risk of thromboembolic events and sepsis from line infections
There is limited data associating TPN with adverse neonatal outcomes (though this needs further study)
Remember Virchow’s triad: pregnant patients are already hypercoagulable, a patient with hyperemesis is often debilitated and in a state of stasis, and a central line itself increases thromboembolism risk—it’s a bad combination

If you have to bypass the mouth, go for tube feeds. Coordinate with MFM and GI, and keep TPN as an absolute last resort.

Summary

Nausea and vomiting of pregnancy affects 50–80% of pregnant patients; etiology is likely driven by rising hCG and estradiol
Hyperemesis gravidarum = persistent vomiting (no other cause) + ketonuria + ≥5% weight loss from pre-pregnancy weight
Prevention: prenatal vitamin ≥1 month before conception, small frequent bland/high-protein meals, avoid sensory triggers
First step when symptoms are present: switch from iron-containing prenatal to folate-only; consider ginger and acupressure bands
Pharmacologic ladder: (1) B6 + doxylamine → (2) dopamine antagonists / antihistamines → (3) ondansetron → (4) steroids
For refractory hyperemesis requiring nutrition support: enteral tube feeds >> TPN; PICC/TPN is an absolute last resort due to thromboembolic and infectious morbidity

That’s it for today! References are listed in the show notes, as is the free OB/GYN Residency Starter Pack. Take care and I’ll see you next week.